(Q40261157)

19 September 2017

title

PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients (English)

1 reference

19 September 2017

Chiya Oshiro

1

1 reference

19 September 2017

Naofumi Kagara

2

1 reference

19 September 2017

Yasuto Naoi

3

1 reference

19 September 2017

Masafumi Shimoda

4

1 reference

19 September 2017

Atsushi Shimomura

5

1 reference

19 September 2017

Naomi Maruyama

6

1 reference

19 September 2017

Kenzo Shimazu

7

1 reference

19 September 2017

Seung Jin Kim

8

1 reference

19 September 2017

Shinzaburo Noguchi

9

1 reference

19 September 2017

language of work or name

English

0 references

publication date

4 March 2015

1 reference

Breast Cancer Research and Treatment

19 September 2017

published in

1 reference

19 September 2017

volume

150

1 reference

19 September 2017

issue

2

1 reference

19 September 2017

page(s)

299-307

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-015-3322-6

19 September 2017

exact match

0 references

cites work

Liquid biopsy: monitoring cancer-genetics in the blood

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3322-6

Liquid biopsies: genotyping circulating tumor DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3322-6

About the possible origin and mechanism of circulating DNA apoptosis and active DNA release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3322-6

Circulating mutant DNA to assess tumor dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3322-6

Rapid clearance of fetal DNA from maternal plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3322-6

Circulating nucleic acids as biomarkers in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3322-6

Comprehensive molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3322-6

Mutant PIK3CA promotes cell growth and invasion of human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3322-6

Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3322-6

Analysis of circulating tumor DNA to monitor metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3322-6

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3322-6

Detection of cancer DNA in plasma of patients with early-stage breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3322-6

Detection of circulating tumor DNA in early- and late-stage human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3322-6

Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3322-6

Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3322-6

Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3322-6

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3322-6

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3322-6

Methylated DNA and total DNA in serum detected by one-step methylation-specific PCR is predictive of poor prognosis for breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3322-6

Evaluation of a RT-PCR based routine screening tool for the detection of disseminated epithelial cells in the bone marrow of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3322-6

Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3322-6

A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3322-6

Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3322-6

10.1007/S10549-015-3322-6

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

19 September 2017

1036030922

0 references

1 reference